Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Midazolam for Dental Sedation in Children
NCT06887712Phase 4Completed
- Sponsor
- Hanoi Medical University
- Start
- Apr 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of midazolam in Dental anxiety (2 arms), sponsored by Hanoi Medical University. Primary endpoints: Sedation Effectiveness (Ramsay Sedation Scale) at 30 months and Amnesic Effectiveness at 1 week. Started Apr 2024; status: completed.
02
Drugs
midazolam
03
Conditions
Dental anxiety
Beyond the preview
Go deeper on NCT06887712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06887712.